Oracle Corp. has been selected as the winning bidder for TikTok’s U.S. operations, the Wall Street Journal reported, after Microsoft Corp. said its bid was rejected by parent company ByteDance Ltd.
Oracle will be announced as TikTok’s “trusted tech partner” in the U.S., the Wall Street Journal reported, citing an unidentified source. The eventual deal won’t be structured as an outright sale, the Journal added.
“ByteDance let us know today they would not be selling TikTok’s US operations to Microsoft,” Redmond, Washington-based Microsoft said in a statement. “We are confident our proposal would have been good for TikTok’s users, while protecting national security interests.”
Subscribe to Eastworld for weekly insight on what’s dominating business in Asia, delivered free to your inbox.
Microsoft, which was working with Walmart Inc., had been seen as the more likely winner earlier in the process, but its talks have cooled, a person with knowledge of the matter said earlier today. Microsoft hadn’t been asked to make revisions to its initial offer in the face of recent signs of opposition to a deal from Chinese government officials, the person added. That’s given competitor Oracle Corp. an upper hand in the negotiations.Play Video
Microsoft said in its statement that it was prepared to make changes aimed at addressing U.S. national security concerns. “To do this, we would have made significant changes to ensure the service met the highest standards for security, privacy, online safety, and combating disinformation, and we made these principles clear in our August statement. We look forward to seeing how the service evolves in these important areas.”
More must-read international coverage from Fortune:
- Trump wants to end U.S. reliance on Chinese manufacturing ‘once and for all.’ U.S. firms aren’t complying
- Hong Kong’s citywide COVID-19 testing has become a barometer of public trust
- Trump has long wanted to kill a Russia-Germany natural gas pipeline. Navalny’s poisoning could do it for him
- More than manufacturing: India’s homegrown COVID vaccines could transform its pharma industry
- China’s top chipmaker could be Trump’s next target in the trade war